FDA — authorised 26 December 1985
- Marketing authorisation holder: MEDA PHARMS
- Status: approved
FDA authorised Cesamet on 26 December 1985
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 26 December 1985.
MEDA PHARMS holds the US marketing authorisation.